RECENT POSTS

18

Jul, 2014

Commercialization and Prototype Development

By: | Tags: , , | Comments: 0

Elisa Kit Development – BioMark has successfully developed Elisa kits using antibodies generated at UBC’s Biomedical Research Centre by Dr. Schrader and his team. The kits were developed under CLSI specifications and are under key customer test site. Double blinded study was also designed to ensure the reliability of the test kits Point Of Care System – Next generation IVD point of care system is being developed in Canada after…

READ MORE

18

Jul, 2014

New Scientific Advisory Board

By: | Tags: , , | Comments: 0

BioMark would like to introduce and welcome 2 new members to its scientific advisory board. The new members are: Dr. Samudra Dissanayake, Director Strategic Initiatives and Business Development Health-Tech-Connex Dr. Dissanayake has been an important contributor in the development…

READ MORE